StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)

Close on Nov 17, 2026Market cap $476.21MP/E –Yield –

Fennec Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Fennec Pharmaceuticals's market cap was $372.76M on Nov 11, 2026, against $229.83M a year earlier. Over the last 5 years it ranged from $114.43M to $432.67M, with a median of $219.32M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$372.76M+72.5%
2025Dec 31, 2025$216.08M+24.7%
2024Dec 31, 2024$173.31M-42.0%
2023Dec 29, 2023$298.84M+18.6%
2022Dec 30, 2022$251.88M+120.1%
2021Dec 31, 2021$114.43M-40.5%
2020Dec 31, 2020$192.28M+48.9%
2019Dec 31, 2019$129.13M+7.7%
2018Dec 31, 2018$119.91M-24.5%
2017Dec 29, 2017$158.89M+544481.6%
2016Dec 30, 2016$29.18K–

More Fennec Pharmaceuticals figures

See a number that looks wrong?